Holen Sie sich die Stockscreener-App
3.73
5.81%
-0.23
Bioaffinity Technologies Inc Aktie (BIAF) Neueste Nachrichten
Form 424B5 bioAffinity Technologies Inc For: 10 October By Investing.com - Investing.com Canada
bioAffinity Technologies closes $4M stock offering on Nasdaq - StreetInsider
bioAffinity Technologies plans $4M stock offering on Nasdaq - StreetInsider
bioAffinity Technologies, Inc. Announces Approximately $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules - Business Wire
Japan intends to grant a patent for a home-collected lung cancer risk test - Stock Titan
More than 1,620 tests to assess lung cancer risk were delivered through Q3 2026. - Stock Titan
Shares could be offered up to 35% below market; bioAffinity Technologies (BIAF) seeks a stockholder vote. - Stock Titan
BIAF Historical Stock Prices & Daily Price Data | bioAffinity Technologies, Inc. Common - Quiver Quantitative
Form 8K bioAffinity Technologies Inc For: 22 September By Investing.com - Investing.com Nigeria
A 2,000-patient study is evaluating a lung cancer test using at-home samples. - Stock Titan
BIAF Stock Soars As Hong Kong Patent Ignites Trading - stockstotrade.com
BIAF Stock Jolts Higher On Nasdaq Win And Federal Deal - stockstotrade.com
bioAffinity Gets Hong Kong Patent for CyPath Lung Test | BIAF Stock News - Stock Titan
bioAffinity Technologies at H.C. Wainwright conference: lung test gains traction - Investing.com Canada
bioAffinity Technologies at H.C. Wainwright conference: lung test gains traction - Investing.com India
bioAffinity Technologies at H.C. Wainwright conference: lung test gains traction - Investing.com UK
BioAffinity Technologies (NASDAQ: BIAF) Announces Presentation Materials for 2026 H.C. Wainwright Global Investment Conference - Kalkine Media
Why Did bioAffinity (NASDAQ:BIAF) Regain Nasdaq Compliance? - Kalkine Media
bioAffinity Regains Nasdaq Compliance, Maintains Capital Market Listing - The Globe and Mail
bioAffinity Regains Nasdaq Compliance, Maintains Capital Market Listing - The Globe and Mail
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
bioAffinity Technologies shares rise after Nasdaq compliance update - Quiver Quantitative
Monday's Gap-Up and Gap-Down Stock Movers: September 8 - ChartMill
BIAF Stock Jumps As Federal Deal Fuels CyPath Lung Momentum - timothysykes.com
bioAffinity Technologies regains Nasdaq compliance after bid-price recovery - TradingView
BIAF Stock Pops As CyPath Lung Wins Federal Distribution - StocksToTrade
Congrats to the folks who joined at $10. Don't forget to give me a like 😘 - Moomoo
bioAffinity Technologies Regains Compliance with Nasdaq Listing Requirements - Yahoo Finance UK
bioAffinity Technologies Regains Compliance with Nasdaq Listing Requirements - Business Wire
bioAffinity Technologies Regains Compliance with Nasdaq Listing Requirements - FinancialContent
Monday's Gap-Up and Gap-Down Stock Movers: September 8 - ChartMill
Top Small Cap Stocks To ConsiderSeptember 7th - MarketBeat
Small Cap Stocks To Follow NowSeptember 5th - MarketBeat
BIAF Stock Slides As bioAffinity’s Dilution And Reverse Split Reshape Trading Setup - stockstotrade.com
bioAffinity’s AI Lung-Cancer Stock Jumped Nearly 48% After a Reverse Split. What Would Have to Go Right? - Yahoo Finance
bioAffinity Technologies to Present Corporate Update at Conference - The Globe and Mail
AOUT, NX, and BIAF stocks soar on strong earnin... - pluang.com
bioAffinity Technologies Inc. Warrant (BIAFW) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
$15.5 to $19.35 🫡 - Moomoo
You know I'm drunk, so my words carry extra weight 😘 - Moomoo
bioAffinity Technologies to Present Corporate Update at Conference - TipRanks
bioAffinity Technologies to Present Corporate Update at H.C. Wainwright Conference; Market Cap ~$5.9M - TradingView
bioAffinity Technologies to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - Yahoo Finance
bioAffinity Technologies and AvMEDICAL Announce Nationwide Federa - The National Law Review
Biotech Stocks To Follow NowSeptember 3rd - MarketBeat
BIAF Stock Pops As Federal Lung Test Deal Fuels Momentum - timothysykes.com
BIAF Stock Jumps As Federal Deal Fuels Lung Test Growth - StocksToTrade
bioAffinity Technologies Shares Rise After CyPath Lung Surveillance Update - Yahoo Finance
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
10.97%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):